INSM FY 2022 Earnings — Insmed Incorporated Revenue & Financial Results | Market Cap Arena

INSMInsmed Incorporated

$31B

FY 2022 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$245M+30.2% YoY

Gross Profit

$190M77.5% margin

Operating Income

-$457M-186.4% margin

Net Income

-$482M-196.3% margin

EPS (Diluted)

$-3.91

Cash Flow

Operating Cash Flow

-$400M

Free Cash Flow

-$410M

Stock-Based Comp.

$58M

Balance Sheet

Total Assets

$1.7B

Total Liabilities

$1.6B

Stockholders' Equity

$88M

Cash & Equivalents

$1.1B

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$245M	$188M	+30.2%
Gross Profit	$190M	$144M	+31.8%
Operating Income	-$457M	-$375M	-21.9%
Net Income	-$482M	-$435M	-10.8%